UNASSIGNED: A 62-year-old @entity1 consulted for evaluation of treatment for her type 2 @entity6 diagnosed four years ago. He had been received treatment with @entity2449 850mg twice, with no chronic associated complications. She had @entity101 and @entity2299 . She was being treated with @entity1564 / @entity918 32/12.5mg and @entity2993 40mg. Her weight was 92kg and height 162cm (BMI, 35.1kg/m(2)). The last analysis showed fasting @entity413 168mg/dl and glycated hemoglobin 7.5%, Microalbuminuria was negative. Blood pressure and lipid profile were within the therapeutic range. Two years ago she suffered a nontraumatic Colle's @entity174 in her left arm for which she was taking a daily @entity460 and @entity560 supplement and weekly @entity561 . In summary, this is an @entity28 female @entity1 with @entity6 and inadequate metabolic control, She also has a history of @entity174 . How should this @entity1 be evaluated and treated?

XXXX and osteoporosis: Action of gastrointestinal hormones on the bone.

@entity1 :: ('9606', 'Species') :: ['woman', 'patient'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes', 'type 2 diabetes mellitus'] @entity2299 :: ('MESH:D050171', 'Disease') :: ['dyslipidemia'] @entity918 :: ('MESH:D006852', 'Chemical') :: ['hydrochlorothiazide'] @entity174 :: ('MESH:D050723', 'Disease') :: ['fragility fracture', 'fracture'] @entity561 :: ('MESH:D019386', 'Chemical') :: ['alendronate'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obese'] @entity2993 :: ('MESH:C065179', 'Chemical') :: ['atorvastatin'] @entity1564 :: ('MESH:C081643', 'Chemical') :: ['candesartan'] @entity460 :: ('MESH:D002118', 'Chemical') :: ['calcium'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity560 :: ('MESH:D014807', 'Chemical') :: ['vitamin D'] @entity2449 :: ('MESH:D008687', 'Chemical') :: ['metformin']
@entity6 :: (MESH:D003920,Disease) :: ['Diabetes']
